Related Experiment Videos
Brain metastases in small cell lung cancer
Aimee L Quan1, Gregory M M Videtic, John H Suh
1Department of Radiation Oncology, Cleveland Clinic, Gamma Knife Center, Brain Tumor Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Oncology (Williston Park, N.Y.)
|August 27, 2004
Summary
Preventing brain metastases is key for aggressive small cell lung cancer (SCLC). Prophylactic cranial irradiation effectively prevents detectable brain disease in SCLC patients who respond to initial treatment.
Area of Science:
- Oncology
- Neurology
Background:
- Small cell lung cancer (SCLC) is an aggressive form of lung cancer, accounting for 20% of all lung cancer cases.
- SCLC has a propensity for early dissemination and a poorer prognosis compared to non-small cell lung cancer.
- Brain metastases are common in SCLC, occurring at diagnosis in 10% and during disease course in 40-50% of patients.
Purpose of the Study:
- To review the current understanding and management of brain metastases in SCLC.
- To emphasize the critical role of prevention in improving outcomes for SCLC patients with brain metastases.
- To highlight prophylactic cranial irradiation as an effective preventive strategy.
Main Methods:
- Literature review of SCLC natural history, metastasis patterns, and treatment outcomes.
- Analysis of standard care protocols for SCLC brain metastases.
- Evaluation of preventive strategies, specifically prophylactic cranial irradiation.
Main Results:
- Brain metastases in SCLC carry a poor prognosis despite extensive research.
- Standard treatment involves medical management and whole brain radiation therapy.
- Prophylactic cranial irradiation is an effective method for preventing clinically detectable brain metastases in SCLC patients achieving a complete response.
Conclusions:
- The most effective strategy for managing SCLC brain metastases is prevention.
- Prophylactic cranial irradiation significantly reduces the incidence of detectable brain metastases.
- Further research into novel agents aims to improve survival and quality of life, but prevention remains paramount.